Structure of the Galapagos CFTR potentiator - GLPG2451

oral CFTR ABC transporter potentiator

Ph. II for cystic fibrosis (5-80 mg QD), discont.

similarity screen of 589 cmpds + scaffold hop

J. Med. Chem., Jan. 5, 2021

Galapagos NV, Mechelen, BE

The Galapagos CFTR potentiator, GLPG2451, is an oral, once-daily clinical candidate for cystic fibrosis (5-80 mg QD). It was advanced into a high-profile Ph. II triple-combo study with the…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.